| Controls (N = 8) | Diabetics (N = 6) |
---|---|---|
Age, years (range) | 44 (28 – 59) | 57 (42 – 71)* |
BMI, kg/m2 | 25.7 ± 3.4 | 30.7 ± 9.4 |
Duration of diabetes (year) | - | 7.7 ± 5 |
Fasting blood glucose (mmol/l) | 4.9 ± 0.4 | 8.5 ± 1.5* |
HbA1c (%) | 5.4 ± 0.2 | 6.8 ± 0.8* |
Total cholesterol (mmol/l) | 5.1 ± 0.8 | 3.7 ± 0.3* |
LDL cholesterol (mmol/l) | 3.1 ± 0.7 | 1.8 ± 0.3* |
HDL cholesterol (mmol/l) | 1.3 ± 0.5 | 1.2 ± 0.4 |
Triglycerides (mmol/l) | 1.4 ± 0.8 | 2.5 ± 2.9 |
Creatinine (μmol/l) | 83 ± 12 | 69 ± 10 |
Urea (mmol/l) | 5.5 ± 0.8 | 5.0 ± 0.9 |
Oral antidiabetic therapy (nr of patients) | Â | Â |
 Metformin |  | 4 |
 Glimepiride |  | 3 |
 Exenatide |  | 1 |
 Gliclazide |  | 1 |
 Liraglutide |  | 1 |
 Pioglitazone |  | 1 |